Fujian Wanchen Biotechnology Co., Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 425.52 million compared to CNY 449.89 million a year ago. Revenue was CNY 425.52 million compared to CNY 449.98 million a year ago. Net income was CNY 24.28 million compared to CNY 96.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.84 a year ago. Diluted earnings per share from continuing operations was CNY 0.17 compared to CNY 0.84 a year ago.